Plusieurs membres du CRYOSTEM participent à la 48ème réunion annuelle de l’EBMT. Voici une sélection de posters et de présentations inscrits dans le cadre du programme scientifique :

Dr Eolia Brissot, membre du Comité Scientifique de CRYOSTEM :
Lundi 21 mars, 09:00 – 10:00 – E1 AML and allogeneic HCT: for whom, how, and when? Chair
Mercredi 23 mars, 12:15 – 13:30 – OS16 Oral session 16: Conditioning  Chair
Lundi 21 mars, 09:00 – 10:00 E1-05 Conclusions Speaker
Mardi 22 mars, 09:00 – 10:15 ALWP-05 Role of bispecific antibodies Speaker
Mercredi 23 mars, 10:45 – 12:00 OS12-07 CD34+ DOSE EFFECTS ON CLINICAL OUTCOMES AFTER FLUDARABINE-BUSULFAN CONDITIONING REGIMEN FOR ACUTE MYELOID LEUKEMIA USING PERIPHERAL BLOOD STEM CELLS – STUDY FROM THE ALWP OF EBMT Oral Presenter
Dimanche 20 mars, 08:30 – 10:00 IS03-04 CAR-T cells in ALL Speaker

Pr Frédéric Baron, membre du Comité Scientifique de CRYOSTEM :
Mardi 22 mars, 14:15 – 15:30 – P2 Optimisation of transplant outcome by modifiable pre- and peri-transplant variables Chair
Mercredi 23 mars, 10:45 – 12:00 – OS12 Oral session 12: Acute leukemia Chair
Samedi 19 mars, 09:50 – 18:00 – P170 HLA-MISMATCHED UNRELATED DONOR TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE VERSUS HLA-HAPLOIDENTICAL TRANSPLANTATION IN PATIENTS WITH ACTIVE ACUTE MYELOID LEUKEMIA Poster Presenter
Samedi 19 mars, 09:50 – 18:00 – P509 HLA-HAPLOIDENTICAL TRANSPLANTATION WITH PTCY IN AML PATIENTS WITH ACTIVE DISEASE AT TRANSPLANTATION: BETTER SURVIVAL WITH BM THAN WITH PBSC IN PATIENTS > 55 YEARS Poster Presenter
Samedi 19 mars, 09:50 – 18:00 – P308 THIRD-DOSE BNT162B2 VACCINE IS HIGHLY EFFICIENT AT INCREASING ANTI-RBD SARS-COV-2 IGG TITERS IN ALLO-HCT RECIPIENTS Poster Presenter

Dr David Michonneau, membre du Comité Stratégique de CRYOSTEM :
Mercredi 23 mars, 10:45 – 12:00 – OS14 Oral session 14: GVHD II, clinical and preclinical Chair
Samedi 19 mars, 09:50 – 18:00 – P216 CLINICAL AND ECONOMIC BURDEN ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (ALLO-HSCT) IN FRANCE Poster Presenter

Dr Marie Robin, membre du Comité Stratégique de CRYOSTEM :
Dr Thomas Luft,  porteur de projet CRYOSTEM :
Mardi 22 mars, 10:45 – 11:45 – E8-02 Endothelial dysfunction in aGVHD Speaker